Skip to content
  • Sunday, 26 July 2026
  • 3:59 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Baylor College of Medicine Researchers Identify Tubulin as a Key Protective Factor Against Alzheimer’s and Parkinson’s Disease Pathogenesis
Neuroscience & Brain Research

Baylor College of Medicine Researchers Identify Tubulin as a Key Protective Factor Against Alzheimer’s and Parkinson’s Disease Pathogenesis

Rifan Muazin Jun 29, 2026 0

In a landmark study that may redefine the therapeutic landscape for neurodegenerative disorders, scientists at Baylor College of Medicine have…

Read More
Neuroscience & Brain Research

Long-Term Exposure to Agricultural Pesticide Chlorpyrifos Linked to 2.5-Fold Increase in Parkinson’s Disease Risk According to UCLA Health Study

Rifan Muazin Jun 29, 2026 0

A comprehensive investigation led by researchers at UCLA Health has established a definitive and alarming link between long-term residential exposure…

Read More
Pharmaceutical R&D

Ionis Pharmaceuticals and Recordati Forge Global Partnership for Zilganersen in Alexander Disease

Teuku Ryan Jun 28, 2026 0

Ionis Pharmaceuticals has forged a significant global licensing agreement with Recordati, a prominent international pharmaceutical company, granting Recordati exclusive rights…

Read More
Neuroscience & Brain Research

Cancer-Driving Mutations in Brain Immune Cells Linked to Alzheimer’s Disease Progression and New Diagnostic Pathways

Rifan Muazin Jun 28, 2026 0

In a landmark study that bridges the fields of oncology and neurology, researchers at Boston Children’s Hospital have identified a…

Read More
Neuroscience & Brain Research

Competition Between Amyloid Beta and Tau for Microtubule Binding Sites Offers New Insight into the Early Pathogenesis of Alzheimer’s Disease

Rifan Muazin Jun 27, 2026 0

Researchers at the University of California, Riverside (UCR) have unveiled a provocative new theory regarding the molecular origins of Alzheimer’s…

Read More
Neuroscience & Brain Research

Breakthrough Molecule OLE Offers New Hope for Restoring Brain Immune Function in Alzheimer Disease Patients

Rifan Muazin Jun 27, 2026 0

In a significant advancement for neurodegenerative research, a collaborative team of scientists from Spain and Switzerland has identified an experimental…

Read More
Laboratory Automation & Robotics

Traumatic brain injury and Alzheimer’s disease: Common neuroinflammatory pathologies and therapeutic potential

Lana Keisha Jun 26, 2026 0

Traumatic brain injury (TBI) stands as a formidable global health challenge, impacting an estimated 69 million individuals annually across all…

Read More
Laboratory Automation & Robotics

How CTF is trying to rescue pharma’s shelved rare disease drugs

Lana Keisha Jun 23, 2026 0

Across the global pharmaceutical landscape, an estimated 5,000 potential treatments for rare diseases are currently languishing on corporate shelves, representing…

Read More
Stem Cell & Regenerative Medicine

Indiana University Researchers Develop Breakthrough Multiplex Imaging Technique for Bone Marrow Analysis to Advance Disease Treatment

Dwi Wanna Jun 23, 2026 0

In a landmark achievement for the field of hematology and regenerative medicine, scientists at the Indiana University School of Medicine…

Read More
Stem Cell & Regenerative Medicine

Paternal Age and the Hidden Genetic Risks: How Natural Selection within the Testes Favors Disease-Causing Mutations in Aging Men

Dwi Wanna Jun 22, 2026 0

New research has unveiled a sophisticated biological mechanism that explains why the risk of passing on genetic disorders increases as…

Read More

Posts pagination

1 … 3 4 5 … 16
The Shifting Landscape of Gene Therapy: Non-Viral Approaches Emerge as Promising AlternativesCoordinated molecular and physiological adaptations enable activity at subfreezing temperature in the snow fly Chionea alexandrianaJeito Capital’s Second Fund Closes Above Target, Bolstering European Biopharma Investment to Over €1.6 BillionGuardrails for LLMs: Measuring AI ‘Hallucination’ and Verbosity
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ